297 related articles for article (PubMed ID: 19413341)
21. Thermodynamic aspects and biological profile of CDAN/DOPE and DC-Chol/DOPE lipoplexes.
Keller M; Jorgensen MR; Perouzel E; Miller AD
Biochemistry; 2003 May; 42(20):6067-77. PubMed ID: 12755608
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.
Kim HR; Wheeler MA; Wilson CM; Iida J; Eng D; Simpson MA; McCarthy JB; Bullard KM
Cancer Res; 2004 Jul; 64(13):4569-76. PubMed ID: 15231668
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
[TBL] [Abstract][Full Text] [Related]
25. In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach.
Varghese OP; Sun W; Hilborn J; Ossipov DA
J Am Chem Soc; 2009 Jul; 131(25):8781-3. PubMed ID: 19499915
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.
Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S
Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932
[TBL] [Abstract][Full Text] [Related]
27. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy.
Martens TF; Peynshaert K; Nascimento TL; Fattal E; Karlstetter M; Langmann T; Picaud S; Demeester J; De Smedt SC; Remaut K; Braeckmans K
Eur J Pharm Sci; 2017 May; 103():27-35. PubMed ID: 28223236
[TBL] [Abstract][Full Text] [Related]
28. An insight on hyaluronic acid in drug targeting and drug delivery.
Yadav AK; Mishra P; Agrawal GP
J Drug Target; 2008 Feb; 16(2):91-107. PubMed ID: 18274931
[TBL] [Abstract][Full Text] [Related]
29. Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells.
Hornof M; de la Fuente M; Hallikainen M; Tammi RH; Urtti A
J Gene Med; 2008 Jan; 10(1):70-80. PubMed ID: 18044795
[TBL] [Abstract][Full Text] [Related]
30. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
de la Fuente M; Seijo B; Alonso MJ
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2016-24. PubMed ID: 18436835
[TBL] [Abstract][Full Text] [Related]
31. Efficient gene transfer into human epithelial cell lines using glycosylated cationic carriers and neutral glycosylated co-lipids.
Montier T; Delépine P; Benvegnu T; Ferrières V; Miramon ML; Dagorn S; Guillaume C; Plusquellec D; Férec C
Blood Cells Mol Dis; 2004; 32(2):271-82. PubMed ID: 15003818
[TBL] [Abstract][Full Text] [Related]
32. CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells: a novel hyaluronic acid-based drug delivery system.
Goodarzi N; Ghahremani MH; Amini M; Atyabi F; Ostad SN; Shabani Ravari N; Nateghian N; Dinarvand R
Chem Biol Drug Des; 2014 Jun; 83(6):741-52. PubMed ID: 24444042
[TBL] [Abstract][Full Text] [Related]
33. Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airways in vivo.
Pitard B; Oudrhiri N; Lambert O; Vivien E; Masson C; Wetzer B; Hauchecorne M; Scherman D; Rigaud JL; Vigneron JP; Lehn JM; Lehn P
J Gene Med; 2001; 3(5):478-87. PubMed ID: 11601761
[TBL] [Abstract][Full Text] [Related]
34. Efficient targeted gene delivery by a novel PAMAM/DNA dendriplex coated with hyaluronic acid.
Urbiola K; Sanmartín C; Blanco-Fernández L; Tros de Ilarduya C
Nanomedicine (Lond); 2014 Dec; 9(18):2787-801. PubMed ID: 24959932
[TBL] [Abstract][Full Text] [Related]
35. Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight.
Park W; Kim KS; Bae BC; Kim YH; Na K
Eur J Pharm Sci; 2010 Jul; 40(4):367-75. PubMed ID: 20417709
[TBL] [Abstract][Full Text] [Related]
36. Efficient cellular labeling by CD44 receptor-mediated uptake of cationic liposomes functionalized with hyaluronic acid and loaded with MRI contrast agents.
Esposito G; Geninatti Crich S; Aime S
ChemMedChem; 2008 Dec; 3(12):1858-62. PubMed ID: 18988207
[No Abstract] [Full Text] [Related]
37. Optimization and characterization of anionic lipoplexes for gene delivery.
Srinivasan C; Burgess DJ
J Control Release; 2009 May; 136(1):62-70. PubMed ID: 19331848
[TBL] [Abstract][Full Text] [Related]
38. Dioleoyl phosphatidylethanolamine and PEG-lipid conjugates modify DNA delivery mediated by 1,4-dihydropyridine amphiphiles.
Hyvönen Z; Rönkkö S; Toppinen MR; Jääskeläinen I; Plotniece A; Urtti A
J Control Release; 2004 Sep; 99(1):177-90. PubMed ID: 15342190
[TBL] [Abstract][Full Text] [Related]
39. Example of fatty acid-loaded lipoplex in enhancing in vitro gene transfer efficacies of cationic amphiphile.
Majeti BK; Karmali PP; Madhavendra SS; Chaudhuri A
Bioconjug Chem; 2005; 16(3):676-84. PubMed ID: 15898737
[TBL] [Abstract][Full Text] [Related]
40. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J
Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
